CLOV - CIK 0001801170
CLOVER HEALTH INVESTMENTS, CORP. /DE trades as CLOV and has a market capitalization of $2.19 B, making it the #2038 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.92B, up 40.3% from the prior year and net income of -$85.55M. This page tracks CLOVER HEALTH INVESTMENTS, CORP. /DE through 617 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 6 fiscal years CLOVER HEALTH INVESTMENTS, CORP. /DE's revenue grew from $462.27M to $1.92B, a compound annual growth rate of 26.8%. Net profit margin expanded from -78.7% to -4.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-19 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-12 |
The largest companies sharing CLOVER HEALTH INVESTMENTS, CORP. /DE's SEC industry classification (hospital & medical service plans).
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) has a market capitalization of $2.19 B as of 2026-05-29, ranking #2038 among US-listed companies.
CLOVER HEALTH INVESTMENTS, CORP. /DE reported revenue of $1.92B for fiscal year 2025, an increase of 40.3% year over year.
In its latest fiscal year CLOVER HEALTH INVESTMENTS, CORP. /DE reported a net loss of $85.55M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.